PERSPECTA

News from every angle

Back to headlines

Medtronic's MiniMed Diabetes Business Seeks $784M in US IPO

Medtronic's diabetes business unit, MiniMed, is reportedly planning an Initial Public Offering (IPO) in the United States, aiming to raise $784 million.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.